Literature DB >> 21494805

In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.

Miroslaw Rybaltowski1, Yuko Suzuki, Hideo Mogami, Iwona Chlebinska, Tomasz Brzoska, Aki Tanaka, Fumiaki Banno, Toshiyuki Miyata, Tetsumei Urano.   

Abstract

To elucidate how unusually large von Willebrand factor (UL-VWF) multimers facilitate thrombus formation, their behavior was analyzed together with that of platelets in living mice deficient in the gene encoding the protease that cleaves UL-VWF, a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13 (ADAMTS13-/-). By crossing ADAMTS13-/- mice with green fluorescent protein-expressing transgenic mice (GFP mice), GFP-ADAMTS13-/- mice were obtained. The dynamics of GFP-expressing platelets were monitored employing intravital confocal fluorescent microscopy. Administration of a vasopressin derivative, DDAVP, a secretagogue of VWF increased the number of platelets adhered to vascular endothelial cells (VECs) on mesentery at sites recognized by an anti-VWF antibody. Some of these platelets were interconnected and aligned as beads on a string. They reached their maximum length at 5 min and were longer in GFP-ADAMTS13-/- mice than in GFP mice (5.3 ± 4.3, N = 6 vs 2.9 ± 2.1 μm, N = 4) (mean±SE). Focal injury of VECs by topical application of FeCl(3) developed longer (25, 3-50 vs 10, 2-25 μm, P < 0.01) (mean, 10th-90th percentile) and more stable (1.3, 0.3-6.3 vs 0.3, 0.2-1.3 s, P < 0.01) connected platelets in GFP-ADAMTS13-/- mice than in GFP mice. This study revealed that ADAMTS13 cleaves platelet-bound UL-VWF multimers, both during their secretion from VECs and after their adherence to injured vascular walls in veins. UL-VWF multimers either being secreted from VECs or circulating in plasma of ADAMTS13-/- mice appeared to facilitate the accumulation of longer and more stable VWF strings with more associated platelets on injured vascular walls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21494805     DOI: 10.1007/s00424-011-0958-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  49 in total

Review 1.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Association of the antagonism of von Willebrand factor but not fibrinogen by platelet alphaIIbbeta3 antagonists with prolongation of bleeding time.

Authors:  T Aoki; Y Tomiyama; S Honda; K Mihara; T Yamanaka; M Okubo; A Moriguchi; S Mutoh
Journal:  J Thromb Haemost       Date:  2005-09-07       Impact factor: 5.824

3.  Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen.

Authors:  Y Asada; A Sumiyoshi; T Hayashi; J Suzumiya; K Kaketani
Journal:  Thromb Res       Date:  1985-06-01       Impact factor: 3.944

4.  ADAMTS13 is expressed in hepatic stellate cells.

Authors:  Wenhua Zhou; Mari Inada; Tai-Ping Lee; Daniel Benten; Sergey Lyubsky; Eric E Bouhassira; Sanjeev Gupta; Han-Mou Tsai
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

5.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

6.  Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit.

Authors:  J A Dent; M Galbusera; Z M Ruggeri
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 8.  von Willebrand factor.

Authors:  Z M Ruggeri; J Ware
Journal:  FASEB J       Date:  1993-02-01       Impact factor: 5.191

9.  Distinct and concerted functions of von Willebrand factor and fibrinogen in mural thrombus growth under high shear flow.

Authors:  Hideto Matsui; Mitsuhiko Sugimoto; Tomohiro Mizuno; Shizuko Tsuji; Shigeki Miyata; Michio Matsuda; Akira Yoshioka
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells.

Authors:  D D Wagner; J B Olmsted; V J Marder
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  6 in total

1.  Visualization of in vivo thromboprophylactic and thrombolytic efficacy of enoxaparin in laser-induced vascular endothelial injury model using multiphoton microscopy.

Authors:  Koji Tanaka; Yuhki Koike; Kohei Matsushita; Masato Okigami; Yuji Toiyama; Mikio Kawamura; Susumu Saigusa; Yoshinaga Okugawa; Yasuhiro Inoue; Keiichi Uchida; Toshimitsu Araki; Yasuhiko Mohri; Akira Mizoguchi; Masato Kusunoki
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

2.  Ex vivo imaging of excised tissue using vital dyes and confocal microscopy.

Authors:  Simon Johnson; Peter Rabinovitch
Journal:  Curr Protoc Cytom       Date:  2012-07

3.  Association between variations in coagulation system genes and carotid plaque.

Authors:  David Della-Morte; Ashley Beecham; Chuanhui Dong; Liyong Wang; Mark S McClendon; Hannah Gardener; Susan H Blanton; Ralph L Sacco; Tatjana Rundek
Journal:  J Neurol Sci       Date:  2012-09-13       Impact factor: 3.181

4.  Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi.

Authors:  Tomasz Brzoska; Aki Tanaka-Murakami; Yuko Suzuki; Hideto Sano; Naohiro Kanayama; Tetsumei Urano
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

5.  BLOC-2 subunit HPS6 deficiency affects the tubulation and secretion of von Willebrand factor from mouse endothelial cells.

Authors:  Jing Ma; Zhe Zhang; Lin Yang; Janos Kriston-Vizi; Daniel F Cutler; Wei Li
Journal:  J Genet Genomics       Date:  2016-10-21       Impact factor: 4.275

6.  Antithrombotic Potential of Tormentil Extract in Animal Models.

Authors:  Natalia Marcinczyk; Dominika Jarmoc; Agnieszka Leszczynska; Agnieszka Zakrzeska; Karol Kramkowski; Jakub Strawa; Anna Gromotowicz-Poplawska; Ewa Chabielska; Michal Tomczyk
Journal:  Front Pharmacol       Date:  2017-08-15       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.